These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

317 related items for PubMed ID: 17848841

  • 1. Efficacy and safety of a new ready-to-use recombinant human growth hormone solution.
    Romer T, Peter F, Saenger P, Starzyk J, Koehler B, Korman E, Walczak M, Wasik R, Ginalska-Malinowska M, Solyom E, Berghout A.
    J Endocrinol Invest; 2007; 30(7):578-89. PubMed ID: 17848841
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
    Hou L, Luo XP, Du ML, Ma HM, Gong CX, Li YC, Shen SX, Zhao ZH, Liang L, Dong GP, Yan CY, Du HW.
    Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
    [Abstract] [Full Text] [Related]

  • 3. The -202 A allele of insulin-like growth factor binding protein-3 (IGFBP3) promoter polymorphism is associated with higher IGFBP-3 serum levels and better growth response to growth hormone treatment in patients with severe growth hormone deficiency.
    Costalonga EF, Antonini SR, Guerra-Junior G, Mendonca BB, Arnhold IJ, Jorge AA.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):588-95. PubMed ID: 18984657
    [Abstract] [Full Text] [Related]

  • 4. Post hoc subgroup analysis of Asian children with paediatric GHD from the global phase 3 efficacy and safety study of once-weekly somatrogon vs. once-daily somatropin.
    Gomez R, Khadilkar V, Shembalkar J, Chu DM, Ko CW, Wajnrajch MP, Wang R.
    J Pediatr Endocrinol Metab; 2024 Jun 25; 37(6):525-531. PubMed ID: 38717038
    [Abstract] [Full Text] [Related]

  • 5. Seven years of safety and efficacy of the recombinant human growth hormone Omnitrope in the treatment of growth hormone deficient children: results of a phase III study.
    Romer T, Saenger P, Peter F, Walczak M, Le Bouc Y, Khan-Boluki J, Berghout A.
    Horm Res; 2009 Jun 25; 72(6):359-69. PubMed ID: 19844125
    [Abstract] [Full Text] [Related]

  • 6. Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age.
    Schwarz HP, Walczak M, Birkholz-Walerzak D, Szalecki M, Nanu M, Woehling H, Schuck E.
    Adv Ther; 2016 Mar 25; 33(3):423-34. PubMed ID: 26886776
    [Abstract] [Full Text] [Related]

  • 7. Long-term safety and efficacy of the recombinant human growth hormone Omnitrope® in the treatment of Spanish growth hormone deficient children: results of a phase III study.
    López-Siguero J, Borrás Pérez MV, Balser S, Khan-Boluki J.
    Adv Ther; 2011 Oct 25; 28(10):879-93. PubMed ID: 21948492
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study.
    Deal CL, Steelman J, Vlachopapadopoulou E, Stawerska R, Silverman LA, Phillip M, Kim HS, Ko C, Malievskiy O, Cara JF, Roland CL, Taylor CT, Valluri SR, Wajnrajch MP, Pastrak A, Miller BS.
    J Clin Endocrinol Metab; 2022 Jun 16; 107(7):e2717-e2728. PubMed ID: 35405011
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind study to assess the efficacy and safety of valtropin, a biosimilar growth hormone, in children with growth hormone deficiency.
    Peterkova V, Arslanoglu I, Bolshova-Zubkovskaya E, Romer T, Zdravkovic D, Kratzsch J, Ji HJ, Savoy C, Saenger P.
    Horm Res; 2007 Jun 16; 68(6):288-93. PubMed ID: 17627092
    [Abstract] [Full Text] [Related]

  • 10. A Randomized Safety and Efficacy Study of Somavaratan (VRS-317), a Long-Acting rhGH, in Pediatric Growth Hormone Deficiency.
    Moore WV, Nguyen HJ, Kletter GB, Miller BS, Rogers D, Ng D, Moore JA, Humphriss E, Cleland JL, Bright GM.
    J Clin Endocrinol Metab; 2016 Mar 16; 101(3):1091-7. PubMed ID: 26672637
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of LB03002, a once-weekly sustained-release human GH for 12-month treatment in Korean children with GH deficiency.
    Hwang JS, Lee HS, Chung WY, Han HS, Jin DK, Kim HS, Ko CW, Lee BC, Lee DY, Lee KH, Shin JH, Suh BK, Yoo HW, Ji HJ, Lee JH, Bae YJ, Kim DH, Yang SW.
    Eur J Endocrinol; 2013 Aug 16; 169(2):179-85. PubMed ID: 23682096
    [Abstract] [Full Text] [Related]

  • 12. Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.
    Iughetti L, Tornese G, Street ME, Napoli F, Giavoli C, Antoniazzi F, Stagi S, Luongo C, Azzolini S, Ragusa L, Bona G, Zecchino C, Aversa T, Persani L, Guazzarotti L, Zecchi E, Pietropoli A, Zucchini S.
    Ital J Pediatr; 2016 Nov 03; 42(1):93. PubMed ID: 27809913
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
    Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA, MS316 Study Group.
    Horm Res Paediatr; 2015 Nov 03; 83(4):268-79. PubMed ID: 25765099
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of Valtropin in the treatment of short stature in girls with Turner's syndrome.
    Peterkova V, Savoy C, Bezlepkina O, Ivanov A, Orlova E, Nagaeva E, Kim J, Lee YP, Saenger PH, Stanhope R.
    J Pediatr Endocrinol Metab; 2004 Oct 03; 17(10):1429-34. PubMed ID: 15526722
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Felicio JS, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Sgarbi JA, Spinola-Castro AM, Cunha MPR, Bandeira F, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M.
    Growth Horm IGF Res; 2019 Oct 03; 48-49():29-35. PubMed ID: 31493626
    [Abstract] [Full Text] [Related]

  • 16. [Effect of recombinant human growth hormone on glucose metabolism in children with growth hormone deficiency].
    Liang L, Zou CC, Li Y, Wang CL, Jiang YJ, Dong GP, Fu JF, Wang XM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 03; 44(9):657-61. PubMed ID: 17217656
    [Abstract] [Full Text] [Related]

  • 17. Reduced Effectiveness and Comparable Safety in Biweekly vs. Weekly PEGylated Recombinant Human Growth Hormone for Children With Growth Hormone Deficiency: A Phase IV Non-Inferiority Threshold Targeted Trial.
    Sun C, Lu B, Liu Y, Zhang Y, Wei H, Hu X, Hu P, Zhao Q, Liu Y, Ye K, Wang K, Gu Z, Liu Z, Ye J, Zhang H, Zhu H, Jiang Z, Liu Y, Wan N, Yan C, Yin J, Ying L, Huang F, Yin Q, Xi L, Luo F, Cheng R.
    Front Endocrinol (Lausanne); 2021 Sep 03; 12():779365. PubMed ID: 34899612
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of PEGylated recombinant human growth hormone in treating Chinese children with growth hormone deficiency: a 5-year retrospective study.
    Hou L, Lin S, Liu Z, Zhang L, Ou H, Huang S, Dai H, Meng Z, Liang L.
    J Pediatr Endocrinol Metab; 2024 Oct 28; 37(10):892-899. PubMed ID: 39190198
    [Abstract] [Full Text] [Related]

  • 19. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
    Jung H, Land C, Nicolay C, De Schepper J, Blum WF, Schönau E.
    Eur J Endocrinol; 2009 Feb 28; 160(2):149-56. PubMed ID: 19039085
    [Abstract] [Full Text] [Related]

  • 20. Effects of recombinant human growth hormone for 1 year on body composition and muscle strength in children on long-term steroid therapy: randomized controlled, delayed-start study.
    Simon D, Alberti C, Alison M, Le Henaff L, Chevenne D, Boizeau P, Canal A, Ollivier G, Decostre V, Jacqz-Aigrain E, Carel JC, Czernichow P, Hogrel JY.
    J Clin Endocrinol Metab; 2013 Jul 28; 98(7):2746-54. PubMed ID: 23626006
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.